INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2012

Evidence for cinnamon's anti-diabetic effects is strong in animal models but conflicting in human clinical trials.

This review summarizes scientific literature on Cinnamomum aromaticum (Cassia) and Cinnamomum zeylanicum bark products. While in vitro and animal studies consistently demonstrated pronounced anti-diabetic and hypoglycemic activities alongside potential antimicrobial, antioxidant, and lipid-lowering properties, results from available human clinical trials remain conflicting. The authors emphasize the need for well-defined, adequately powered randomized controlled clinical trials before recommending cinnamon as an effective human treatment.

Study type
Narrative review
Who was studied
Human clinical trials, animal models, and in vitro studies
What was measured
Hypoglycaemic activity, lipid-lowering, blood pressure, and other bioactivities

THE PAPER

Bioactivity of cinnamon with special emphasis on diabetes mellitus: a review.

Bandara T, Uluwaduge I, Jansz ER. Int J Food Sci Nutr, 2012.

PubMed 22007625 ↗DOI 10.3109/09637486.2011.627849 ↗

Heart & arteriesDiabetes & blood sugarBlood pressure

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.